1. Home
  2. CECO vs VKTX Comparison

CECO vs VKTX Comparison

Compare CECO & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CECO Environmental Corp.

CECO

CECO Environmental Corp.

N/A

Current Price

$75.39

Market Cap

4.1B

Sector

Industrials

ML Signal

N/A

VKTX

Viking Therapeutics Inc.

N/A

Current Price

$32.13

Market Cap

4.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CECO
VKTX
Founded
1966
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Pollution Control Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.1B
4.0B
IPO Year
2002
2014

Fundamental Metrics

Financial Performance
Metric
CECO
VKTX
Price
$75.39
$32.13
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
7
Target Price
$80.25
$95.86
AVG Volume (30 Days)
676.0K
1.7M
Earning Date
04-28-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
280.56
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$24.84
N/A
Revenue Next Year
$11.51
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$42.85
$22.96
52 Week High
$101.24
$43.15

Technical Indicators

Market Signals
Indicator
CECO
VKTX
Relative Strength Index (RSI) 52.27 42.69
Support Level $74.17 $31.58
Resistance Level $83.24 $32.92
Average True Range (ATR) 3.46 1.37
MACD 0.83 -0.05
Stochastic Oscillator 54.57 17.91

Price Performance

Historical Comparison
CECO
VKTX

About CECO CECO Environmental Corp.

CECO Environmental Corp is an industrial company, serving industrial air, industrial water, and energy transition markets. It offers various engineered and configured products and solutions, including dampers and diverters, selective catalytic reduction systems, severe-service and industrial cyclones, dust collectors, thermal oxidizers, filtration systems, wet and dry scrubbers, water treatment packages, industrial silencers, etc. These products are offered through brands like Western Airducts, WK, Wakefield Acoustics, Transcend, Verantis, and others. The company's reportable segments are: Engineered Systems, which derive maximum revenue, and Industrial Process Solutions. Geographically, it derives key revenue from the U.S., followed by the Netherlands, the UK, China, and other markets.

About VKTX Viking Therapeutics Inc.

Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.

Share on Social Networks: